
Sign up to save your podcasts
Or


MRD (minimal/measurable residual disease) testing is changing the way doctors understand and monitor blood cancers. In this episode, we talk with Dr. John Burke of the Rocky Mountain Cancer Center about how MRD testing works, what the results mean to patients and their care teams, and how ongoing clinical research is helping shape more personalized and hopeful approaches to treatment.
Mentioned on this episode:
Additional LLS Support Resources:
Supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.
The post MRD Explained: What it Means for You and Your Care first appeared on The Bloodline with Blood Cancer United Podcast.
By Blood Cancer UnitedMRD (minimal/measurable residual disease) testing is changing the way doctors understand and monitor blood cancers. In this episode, we talk with Dr. John Burke of the Rocky Mountain Cancer Center about how MRD testing works, what the results mean to patients and their care teams, and how ongoing clinical research is helping shape more personalized and hopeful approaches to treatment.
Mentioned on this episode:
Additional LLS Support Resources:
Supported by Adaptive Biotechnologies Corporation and Allogene Therapeutics.
The post MRD Explained: What it Means for You and Your Care first appeared on The Bloodline with Blood Cancer United Podcast.